Avicularin
CAS No. 572-30-5
Avicularin( —— )
Catalog No. M18833 CAS No. 572-30-5
Avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 408 | In Stock |
|
| 100MG | 603 | In Stock |
|
| 200MG | 860 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAvicularin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAvicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
-
DescriptionAvicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells. Avicularin inhibits the accumulation of the intracellular lipids by decreasing C/EBPα-activated GLUT4-mediated glucose uptake in adipocytes and potently inhibiting fatty acid synthase.
-
In VitroCell Proliferation Assay Cell Line:Huh7 cells Concentration:25, 50, 100 μg/mL Incubation Time:12, 24, 36 and 48 h Result:Inhibited cell proliferation in a dose-dependent manner.Western Blot Analysis Cell Line:RAW 264.7 cells Concentration:10, 30, 100, 300 μM Incubation Time:1 h Result:Inhibited LPS-induced protein expression of iNOS and COX-2, release of pro-inflammatory cytokine IL-1β, degradation of cytosolic IκB, and phosphorylation of ERK.RT-PCR Cell Line:3T3-L1 cells Concentration:50 μM Incubation Time:6 days Result:Decreased PPARγ, C/EBPα, and aP2 mRNA levels approximately 28.7, 69.5, and 18.3%, respectively.
-
In VivoAnimal Model:ACLT (anterior cruciate ligament transection)-induced rats Dosage:0.5, 1, 2 mg/kg Administration:Injected into the articular cavity of the right knee, twice a week for 4 weeks.Result:Alleviated the tibial subchondral osteolysis, reduces bone loss, and increases the bone mass of tibial subchondral bone.Attenuated ECM degradation, the loss of Aggrecan and Collagen II in ACLT-induced rats. Decreased the MMP3 and MMP13 protein level. Animal Model:Rats with amyloid Beta-induced Alzheimer's disease Dosage:25, 50, and 100 mg/kg Administration:Oral administration, for 21 days Result:Enhanced cognition activity, and reversed the effects of amyloid beta-induced inflammatory response and excessive oxidative stress.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorERK
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number572-30-5
-
Formula Weight434.35
-
Molecular FormulaC20H18O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (230.23 mM)
-
SMILESC1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(O4)CO)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Mesaconitine
Mesaconitine has antinociceptive activity through cyclic AMP and stimulation of the central β-adrenergic system.
-
GM-CSF
GM-CSF
-
Retinyl propionate
Vitamin A Propionate is an ester compound of vitamin A. In nutritional studies of foals, different doses have different effects on growth, serum biochemistry and hematological indicators. Too high or too low doses will produce adverse effects and are related to the vitamin A concentration in plasma, liver and kidneys.
Cart
sales@molnova.com